跳到正文

MCKESSON CORP

MCK · XNYS

CIK 927653fmd_14M0XKGNY8HHJ6D503CFRMPFK8批发业 · 批发-药品、专利药及药店杂品模板: 标准

覆盖范围: 2007年4月01日 至 2026年9月30日,共 75 个期间

利润表 · 年度 · 百万 · USD
项目FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
营业总收入198,533208,357214,319231,051238,228263,966276,711308,951359,051403,430
营业成本187,262197,173202,565219,028226,080250,836264,353296,123345,728388,880
毛利润11,27111,18411,75412,02312,14813,13012,35812,82813,32314,550
研发费用3411257196––––––
销售、一般及管理费用7,4478,1388,4379,1828,84910,5377,7768,6578,5078,096
营业费用合计4,14910,42210,8689,53417,18811,0927,9778,9198,9018,338
营业利润7,1227628862,489(5,040)2,0384,3813,9094,4226,212
利息费用308283264249217178248252265247
利息及投资收益294839491210107118173179
其他营业外收入(支出)7713018212223259497132202236
税前利润6,8912396101,144(5,034)1,9284,6303,7894,3596,201
所得税费用1,614(53)35618(695)6369056298781,102
持续经营净利润5,2772922541,126(4,339)1,2923,7253,1603,4815,099
净利润5,0706734900(4,539)1,1143,5603,0023,2954,762
归属于普通股股东的净利润––––––––––
MCKESSON CORP (MCK) 财务报表 · FinancialMD